Akero Therapeutics, Inc.
AKRODelisted Dec 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001744659
Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Akero Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 157
- −23 vs. Q3 2023
- Shares held
- 59.0M
- +1.94M (+3.4%) vs. Q3 2023
- Total value
- $1.38B
- −$1.52B (−52.5%) vs. Q3 2023
- New holders
- 31
- 59 more added
- Sold out
- 54
- 45 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AKRO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 5 | $533.0K |
| Q3 2025 | 265 | $4.34B |
| Q2 2025 | 257 | $4.92B |
| Q1 2025 | 240 | $3.50B |
| Q4 2024 | 191 | $2.06B |
| Q3 2024 | 168 | $2.09B |
| Q2 2024 | 153 | $1.68B |
| Q1 2024 | 173 | $1.85B |
| Q4 2023 | 157 | $1.38B |
| Q3 2023 | 181 | $2.90B |
| Q2 2023 | 157 | $2.63B |
| Q1 2023 | 156 | $1.84B |
| Q4 2022 | 162 | $2.66B |
| Q3 2022 | 146 | $1.59B |
| Q2 2022 | 113 | $329.6M |
| Q1 2022 | 103 | $499.2M |
| Q4 2021 | 97 | $746.8M |
| Q3 2021 | 103 | $626.0M |
| Q2 2021 | 97 | $684.2M |
| Q1 2021 | 109 | $913.6M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Akero Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Propel Bio Management, LLC | 100,052 | $2.34M | 1.94% | +100,052 | New |
| Walleye Trading LLC | 116,054 | $2.71M | 0.04% | +491+0.4% | Added |
| Emerald Mutual Fund Advisers Trust | 116,081 | $2.71M | 0.14% | +116,081 | New |
| Walleye Capital LLC | 130,017 | $3.04M | 0.04% | +130,017 | New |
| Nuveen Asset Management, LLC | 132,141 | $3.09M | 0.00% | +658+0.5% | Added |
| Schonfeld Strategic Advisors LLC | 134,352 | $3.14M | 0.03% | −77,656−36.6% | Reduced |
| Qube Research & Technologies Ltd | 136,828 | $3.19M | 0.01% | +136,828 | New |
| Emerald Advisers, LLC | 139,690 | $3.26M | 0.14% | +139,690 | New |
| JPMorgan Chase & Co | 152,878 | $3.57M | 0.00% | −561,700−78.6% | Reduced |
| Voloridge Investment Management, LLC | 174,222 | $4.07M | 0.02% | +174,222 | New |
| Bank of New York Mellon Corp | 177,795 | $4.15M | 0.00% | −322,450−64.5% | Reduced |
| Candriam Luxembourg S.C.A. | 184,000 | $4.30M | 0.03% | +84,000+84.0% | Added |
| Citigroup Inc | 188,452 | $4.40M | 0.01% | +91,962+95.3% | Added |
| Deutsche Bank AG | 190,211 | $4.44M | 0.00% | +79,612+72.0% | Added |
| Balyasny Asset Management LLC | 198,271 | $4.63M | 0.01% | +158,988+404.7% | Added |
| D. E. Shaw & Co., Inc. | 210,960 | $4.93M | 0.01% | +74,062+54.1% | Added |
| BNP Paribas Arbitrage, SA | 212,212 | $4.96M | 0.01% | +152,691+256.5% | Added |
| Ensign Peak Advisors, Inc | 233,264 | $5.45M | 0.01% | +650+0.3% | Added |
| Avidity Partners Management LP | 235,000 | $5.49M | 0.21% | −504,100−68.2% | Reduced |
| Barclays PLC | 246,274 | $5.75M | 0.00% | +114,828+87.4% | Added |
| Ameriprise Financial Inc | 246,893 | $5.76M | 0.00% | +226,255+1,096.3% | Added |
| Silverarc Capital Management, LLC | 249,254 | $5.82M | 1.79% | +217,918+695.4% | Added |
| Jane Street Group, LLC | 255,549 | $5.97M | 0.01% | +79,513+45.2% | Added |
| Millennium Management LLC | 257,194 | $6.01M | 0.01% | +257,194 | New |
| UBS Group AG | 266,386 | $6.22M | 0.00% | +207,983+356.1% | Added |
| Adage Capital Partners GP, L.L.C. | 275,000 | $6.42M | 0.01% | −1,668,009−85.8% | Reduced |
| Artisan Partners Limited Partnership | 303,920 | $7.10M | 0.01% | −7,116−2.3% | Reduced |
| Atlas Venture Life Science Advisors, LLC | 359,251 | $8.39M | 1.00% | 00.0% | Unchanged |
| University of Wisconsin Foundation | 372,575 | $8.70M | 14.48% | +268,759+258.9% | Added |
| Charles Schwab Investment Management Inc | 425,545 | $9.94M | 0.00% | +6,115+1.5% | Added |
| Rafferty Asset Management, LLC | 451,832 | $10.6M | 0.04% | +268,335+146.2% | Added |
| Citadel Advisors LLC | 485,025 | $11.3M | 0.01% | +182,438+60.3% | Added |
| Bank of America Corp | 489,641 | $11.4M | 0.00% | +294,756+151.2% | Added |
| Long Focus Capital Management, LLC | 510,000 | $11.9M | 1.54% | +366,000+254.2% | Added |
| Northern Trust Corp | 540,685 | $12.6M | 0.00% | +2,662+0.5% | Added |
| Commodore Capital LP | 565,000 | $13.2M | 1.15% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 613,275 | $14.3M | 0.00% | +282,190+85.2% | Added |
| Point72 Asset Management, L.P. | 644,305 | $15.0M | 0.05% | +605,705+1,569.2% | Added |
| Logos Global Management LP | 800,000 | $18.7M | 2.08% | +200,000+33.3% | Added |
| Perceptive Advisors LLC | 967,775 | $22.6M | 0.51% | −651,650−40.2% | Reduced |
| Morgan Stanley | 1,057,327 | $24.7M | 0.00% | +617,591+140.4% | Added |
| Rock Springs Capital Management LP | 1,081,064 | $25.2M | 0.62% | −338,086−23.8% | Reduced |
| Redmile Group, LLC | 1,109,476 | $25.9M | 0.93% | −660,208−37.3% | Reduced |
| Geode Capital Management, LLC | 1,166,245 | $27.2M | 0.00% | +62,939+5.7% | Added |
| Alliancebernstein L.P. | 1,607,691 | $37.5M | 0.01% | +325,981+25.4% | Added |
| Boxer Capital, LLC | 1,676,733 | $39.2M | 1.95% | 00.0% | Unchanged |
| General Atlantic LLC | 1,785,714 | $41.7M | 0.60% | 00.0% | Unchanged |
| Yiheng Capital Management, L.P. | 1,923,674 | $44.9M | 5.56% | +702,000+57.5% | Added |
| Baker Bros. Advisors LP | 2,368,378 | $55.3M | 0.63% | 00.0% | Unchanged |
| Wellington Management Group LLP | 2,881,989 | $67.3M | 0.01% | +2,053,028+247.7% | Added |
| Vanguard Group Inc | 3,085,048 | $72.0M | 0.00% | +72,866+2.4% | Added |
| RTW Investments, LP | 3,592,759 | $83.9M | 1.31% | +3,592,759 | New |
| Price T Rowe Associates Inc | 3,675,924 | $85.8M | 0.01% | −134,270−3.5% | Reduced |
| Alkeon Capital Management LLC | 3,764,220 | $87.9M | 0.58% | −3,160−0.1% | Reduced |
| BlackRock Inc. | 4,180,507 | $97.6M | 0.00% | +203,187+5.1% | Added |
| Janus Henderson Group PLC | 4,306,401 | $100.6M | 0.06% | −180,325−4.0% | Reduced |
| State Street Corp | 5,122,895 | $119.6M | 0.01% | +2,617,047+104.4% | Added |
| Lord, Abbett & Co. LLC | 0 | $0 | 0.00% | −779,126−100.0% | Sold out |
| Avoro Capital Advisors LLC | 0 | $0 | 0.00% | −555,555−100.0% | Sold out |
| Eventide Asset Management, LLC | 0 | $0 | 0.00% | −513,876−100.0% | Sold out |
| Pictet Asset Management Holding SA | 0 | $0 | 0.00% | −399,285−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −350,000−100.0% | Sold out |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 0 | $0 | 0.00% | −273,002−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −260,535−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −214,298−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −198,500−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −116,107−100.0% | Sold out |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −115,000−100.0% | Sold out |
| Bridger Management, LLC | 0 | $0 | 0.00% | −101,500−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Peregrine Capital Management LLC | 0 | $0 | 0.00% | −95,447−100.0% | Sold out |
| Clough Capital Partners L P | 0 | $0 | 0.00% | −72,200−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −54,780−100.0% | Sold out |
| State of New Jersey Common Pension Fund D | 0 | $0 | 0.00% | −50,259−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −42,620−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −40,280−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −33,800−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −33,582−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −31,881−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −29,649−100.0% | Sold out |
| Bellevue Group AG | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −22,785−100.0% | Sold out |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −21,873−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −21,260−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −20,597−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −18,908−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −15,986−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −14,280−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −12,931−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −11,408−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −11,243−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −9,426−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −8,122−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −8,060−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| Woodmont Investment Counsel LLC | 0 | $0 | 0.00% | −6,620−100.0% | Sold out |
| Knott David M Jr | 0 | $0 | 0.00% | −6,419−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −5,634−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −5,027−100.0% | Sold out |